A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is $172.03, with a 24-hour trading volume of $341.79M. The asset's market cap is $266.79B, after moving 1.41% in the last day.
Tokenized AstraZeneca PLC is trading at $95.9, with a tokenized market cap of $54.29M and a 24-hour trading volume of $809.62K. The tokenized asset has moved -0.13% in the past 24 hours.